PIM1 and prostate cancer: Therefore, we identified and mutated the PIM targets sites from NFATC1 and analysed the impact of these mutations in three prostate cancer cell lines, the hormone-insensitive PC-3 and DU-145 cells and the hormone-sensitive LNCaP cells.